Brief: Myriad Genetics Announces Five Research Collaborations To Study The Use Of Mrd Testing In Breast Cancer
08/10/2024 21:34
Oct 8 (Reuters) - Myriad Genetics Inc MYGN.O :
* MYRIAD GENETICS ANNOUNCES FIVE RESEARCH COLLABORATIONS TO
STUDY
THE USE OF MRD TESTING IN BREAST CANCER
Source text for Eikon: ID:nGNX3RH2fs
Further company coverage: MYGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Myriad Genetics
See all newsUS STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
US STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
Myriad jumps after agreeing to sell prenatal health testing business
Brief: Myriad Genetics To Sell Prenatal Health Testing Business To Labcorp
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple